Primordial Genetics attends Synbiobeta Conference in San Francisco, CA

The principal aim of this project is to apply a novel synthetic biology approach to develop protein expression strains...

This week, Primordial Genetics signed a Letter of Intent with a San Diego-based pharmaceutical company (‘Company A’), for a...

Primordial Genetics today announced the first closing of its Series A-2 financing round, including a group of 5 private...

Following the launch of an R&D project for improvement of an enzyme used for manufacturing high-value pharmaceuticals in November...